Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
IMAX
IMAX
$2.73B
| $2.28M | ﹤0.01% |
203,132
+88,842
| +78% | +$1.04M |
|
|
CGO
3402
Calamos Global Total Return Fund
CGO
$128M
| $2.27M | ﹤0.01% |
200,444
+19,075
| +11% | +$196K |
|
|
SWIR
3403
DELISTED
Sierra Wireless
SWIR
| $2.27M | ﹤0.01% |
252,798
-237,667
| -48% | -$2.03M |
|
3404
Arcus Biosciences
RCUS
$3.61B
| $2.27M | ﹤0.01% |
91,582
+88,341
| +2,726% | +$2.38M |
|
3405
Milestone Pharmaceuticals
MIST
$147M
| $2.26M | ﹤0.01% |
598,389
+553,151
| +1,223% | +$1.78M |
|
|
HIBB
3406
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $2.26M | ﹤0.01% |
107,990
-98,270
| -48% | -$1.64M |
|
3407
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$461M
| $2.26M | ﹤0.01% |
67,220
+8,813
| +15% | +$287K |
|
|
NEV
3408
DELISTED
NUVEEN ENHANCED MUNICIPAL VALUE FUND
NEV
| $2.26M | ﹤0.01% |
154,907
+31,006
| +25% | +$419K |
|
|
EOT
3409
Eaton Vance National Municipal Opportunities Trust
EOT
$272M
| $2.25M | ﹤0.01% |
114,741
-12,567
| -10% | -$236K |
|
|
ADSW
3410
DELISTED
Advanced Disposal Services Inc
ADSW
| $2.25M | ﹤0.01% |
74,755
+17,031
| +30% | +$544K |
|
3411
ProShares Trust Short MSCI EAFE
EFZ
$10.1M
| $2.25M | ﹤0.01% |
44,869
-222,701
| -83% | -$12.1M |
|
|
VBTX
3412
DELISTED
Veritex Holdings
VBTX
| $2.25M | ﹤0.01% |
127,173
+7,110
| +6% | +$115K |
|
3413
Mercury Insurance
MCY
$5.95B
| $2.25M | ﹤0.01% |
55,185
-78,528
| -59% | -$3.15M |
|
3414
TechTarget
TTGT
$312M
| $2.25M | ﹤0.01% |
74,872
+11,628
| +18% | +$293K |
|
|
EBIX
3415
DELISTED
Ebix Inc
EBIX
| $2.25M | ﹤0.01% |
100,414
+10,096
| +11% | +$208K |
|
|
MTEM
3416
DELISTED
Molecular Templates, Inc.
MTEM
| $2.24M | ﹤0.01% |
10,824
+10,493
| +3,170% | +$2.44M |
|
|
ATAXZ
3417
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
| $2.24M | ﹤0.01% |
543,720
+164,799
| +43% | +$679K |
|
|
AXNX
3418
DELISTED
Axonics, Inc. Common Stock
AXNX
| $2.23M | ﹤0.01% |
63,670
+6,614
| +12% | +$228K |
|
3419
Nuveen Virginia Quality Municipal Income Fund
NPV
$212M
| $2.23M | ﹤0.01% |
156,138
-8,880
| -5% | -$117K |
|
3420
OraSure Technologies
OSUR
$275M
| $2.23M | ﹤0.01% |
191,699
+25,743
| +16% | +$334K |
|
3421
Syndax Pharmaceuticals
SNDX
$1.76B
| $2.22M | ﹤0.01% |
150,065
+79,301
| +112% | +$1.21M |
|
3422
Rayonier
RYN
$6.45B
| $2.22M | ﹤0.01% |
98,828
-18,494
| -16% | -$402K |
|
|
SASR
3423
DELISTED
Sandy Spring Bancorp Inc
SASR
| $2.22M | ﹤0.01% |
89,621
+44,226
| +97% | +$1.05M |
|
|
ZGNX
3424
DELISTED
Zogenix, Inc.
ZGNX
| $2.22M | ﹤0.01% |
82,132
+41,760
| +103% | +$1.15M |
|
|
XLRN
3425
DELISTED
Acceleron Pharma
XLRN
| $2.22M | ﹤0.01% |
23,286
-3,839
| -14% | -$370K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,644 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.